These data suggest that FMD in combination with chemotherapy may enhance T cell-dependent targeted killing of cancer cells by stimulating the hematopoietic system and enhancing CD8 T cell-dependent tumor cytotoxicity [101]. Here, CD8A is linked to cancer.